NCT04606238 (PETUPAL) is a NA clinical trial of Decision Aid in Advanced Cancer, sponsored by University Hospital Heidelberg.

Who is sponsoring NCT04606238?

NCT04606238 is sponsored by University Hospital Heidelberg.

What drugs are being tested in NCT04606238?

Interventions in NCT04606238: Decision Aid.

What condition does NCT04606238 study?

NCT04606238 studies Advanced Cancer.

Is NCT04606238 still recruiting?

NCT04606238 is currently status unknown. Last updated 10 January 2023.

Last reviewed 2023-01-10 · How we verify

NCT04606238: PETUPAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Decision Aid to Support Advanced Cancer Patients

Status unknown NA Last updated 10 January 2023

What this trial tests

NA trial testing Decision Aid in Advanced Cancer in 70 participants. Status unknown.

Timeline

1 October 2019

Primary endpoint
1 February 2023

1 April 2023

Quick facts

Lead sponsor	University Hospital Heidelberg
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	70
Start date	1 October 2019
Primary completion	1 February 2023
Estimated completion	1 April 2023
Sites	1 location across Germany

Drugs / interventions tested

Decision Aid

Conditions studied

Advanced Cancer — all drugs for Advanced Cancer →

Sponsor

University Hospital Heidelberg

Who can join

18 and older, any sex, with Advanced Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To support advanced cancer patients, for whom standard therapy is no longer available, and their oncologists in therapy decisions, the investigators aim to develop a decision-making aid (DA) in a multi-phased bicentric study. The DA aims to help patients to understand better risks and benefits of available treatment options including the options of standard palliative care, off-label drug use within an individual treatment plan and involvement in early clinical trials.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Development and Evaluation of a Decision Aid to Support Patients' Participatory Decision-Making for Tumor-Specific and Palliative Therapy for Advanced Cancer: Protocol for a Pre-Post Study.
Laryionava K, Schildmann J, Wensing M, Wedding U, et al · · 2021 · cited 2× · PMID 34533464 · DOI 10.2196/24954
Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned.
Laryionava K, Boekels R, Schildmann J, Wensing M, et al · · 2024 · cited 1× · PMID 39690895 · DOI 10.1002/cam4.70127

Verify or expand the search:

Other trials of Decision Aid

Trials testing the same drug.

NCT07536412 — Decision Aid Efficacy in Low Risk Thyroid Cancer · NA · not yet recruiting
NCT06980103 — Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyro · NA · recruiting
NCT06171737 — Promoting Shared Decision Making for Severe Aortic Stenosis · NA · enrolling by invitation
NCT05547048 — Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women · Phase 4 · recruiting
NCT05477420 — Effect of Web-based Decision Aids on Preferences Shift · NA · completed

Other recruiting trials for Advanced Cancer

Currently open trials in the same condition.

NCT07393529 — A Pilot Randomized Controlled Trial of a Social Network Intervention · NA · recruiting
NCT07382544 — Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss · Phase 1 · recruiting
NCT07246954 — A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in P · NA · recruiting
NCT06346197 — Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas · Phase 3 · recruiting
NCT07147023 — Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication · NA · active not recruiting

Other University Hospital Heidelberg trials

Trials by the same sponsor.

NCT07388147 — Exercise Therapy for Multiple Myeloma Patients · NA · not yet recruiting
NCT07348874 — Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany · not yet recruiting
NCT07181928 — Is Mentalization-based Therapy More Effective Than Treatment-as-usual for Adolescents With Dissocial Disorders? · NA · not yet recruiting
NCT06954623 — Partial Breast Re-irradiation for Breast Cancer · NA · recruiting
NCT06913010 — DV 100 as a Framework for the Hospital Incident Command System · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04606238 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Heidelberg
Last refreshed: 10 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04606238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing